Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BGB-16673

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drug

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Rotigotine

Contact Research Centre

Hormone receptor positive breast cancer+2

Recruiting

Registered drugNo placebo

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Nervous system disorder

Not yet recruiting

Registered drugNo placebo

Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ocrelizumab

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Neuralgia+1

Not recruiting

Investigational

Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:LY3848575

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Methylprednisolone

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Investigational

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Quinidine Sulfate

Contact Research Centre

Schizophrenia

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Germany

Participants:18–64 years
Substances:Iclepertin

Contact Research Centre

Neuralgia

Not recruiting

Registered drug

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Paracetamol

Contact Research Centre

Major depression

Not recruiting

Registered drug

Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Citalopram

Contact Research Centre

Find therapies in clinical trials near you

22 trials match your criteria

Chronic lymphocytic leukaemia+1

A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

Triple negative breast cancer

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Dementia Alzheimer's type

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Hormone receptor positive breast cancer+2

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Nervous system disorder

Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

Dementia Alzheimer's type

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Neuralgia+1

Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

Multiple sclerosis+1

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Dementia Alzheimer's type

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Schizophrenia

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Neuralgia

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Major depression

Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.